ロード中...
Optimizing antiviral agents for hepatitis B management in malignant lymphomas
The global scale of hepatitis B infection is well known but its impact is still being understood. Missed hepatitis B infection impacts lymphoma therapy especially increased risk of hepatitis B virus (HBV) reactivation and poor treatment outcomes. The presence of undiagnosed chronic hepatitis also un...
保存先:
| 出版年: | Ann Transl Med |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5326643/ https://ncbi.nlm.nih.gov/pubmed/28251118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.12.25 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|